×
About 615 results

ALLMedicine™ Protein C Deficiency Center

Research & Reviews  295 results

Acute subdural haemorrhage complicating cerebral venous thrombosis in a patient with pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705573
BMJ Case Reports; Lim EYT, Pai V et. al.

Dec 1st, 2020 - Cerebral venous thrombosis (CVT) directly causing subdural haemorrhage (SDH) is a rare entity. We present a case of an 18-year-old female patient who presented with severe occipital headache. Neuroimaging showed acute SDH and CVT. She was eventual...

Diffuse Intracerebral Hemorrhage in an Infant With a Novel Homozygous Variant Leading t...
https://doi.org/10.1097/MPH.0000000000001993
Journal of Pediatric Hematology/oncology; Martin G, Thomas MA et. al.

Nov 9th, 2020 - Protein C is a circulating anticoagulant that inhibits factor Va and VIIIa and promotes fibrinolysis. Compound heterozygous or homozygous variants in the Protein C gene (PROC) lead to severe deficiency of protein C and affected neonates typically ...

Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japan...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105320
Journal of Stroke and Cerebrovascular Diseases : the Offi... Saito K, Ishii K et. al.

Nov 2nd, 2020 - We herein report a case involving a 32-year-old Japanese man with recurrent cerebral venous thrombosis due to hereditary protein C deficiency. He was admitted to our hospital with impaired consciousness. Brain magnetic resonance imaging demonstrat...

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders.
https://doi.org/10.1177/1060028020968551
The Annals of Pharmacotherapy; Valanejad SM, Davis KA

Oct 26th, 2020 - To summarize the literature assessing the safety and efficacy of direct oral anticoagulants (DOACs) for the acute treatment and secondary prevention of venous thromboembolism (VTE) in select patients with hypercoagulable disorders. An electronic P...

see more →

Guidelines  1 results

CEPROTIN [Protein C Concentrate (Human)]
http://www.ceprotin.com/

CEPROTIN is FDA-approved in the United States and registered in more than 35 countries worldwide. See Full Indication and Important Safety Information. CEPROTIN is indicated for pediatric and adult patients with severe congenital Protein C deficie...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  305 results

Acute subdural haemorrhage complicating cerebral venous thrombosis in a patient with pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705573
BMJ Case Reports; Lim EYT, Pai V et. al.

Dec 1st, 2020 - Cerebral venous thrombosis (CVT) directly causing subdural haemorrhage (SDH) is a rare entity. We present a case of an 18-year-old female patient who presented with severe occipital headache. Neuroimaging showed acute SDH and CVT. She was eventual...

Diffuse Intracerebral Hemorrhage in an Infant With a Novel Homozygous Variant Leading t...
https://doi.org/10.1097/MPH.0000000000001993
Journal of Pediatric Hematology/oncology; Martin G, Thomas MA et. al.

Nov 9th, 2020 - Protein C is a circulating anticoagulant that inhibits factor Va and VIIIa and promotes fibrinolysis. Compound heterozygous or homozygous variants in the Protein C gene (PROC) lead to severe deficiency of protein C and affected neonates typically ...

Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japan...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105320
Journal of Stroke and Cerebrovascular Diseases : the Offi... Saito K, Ishii K et. al.

Nov 2nd, 2020 - We herein report a case involving a 32-year-old Japanese man with recurrent cerebral venous thrombosis due to hereditary protein C deficiency. He was admitted to our hospital with impaired consciousness. Brain magnetic resonance imaging demonstrat...

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders.
https://doi.org/10.1177/1060028020968551
The Annals of Pharmacotherapy; Valanejad SM, Davis KA

Oct 26th, 2020 - To summarize the literature assessing the safety and efficacy of direct oral anticoagulants (DOACs) for the acute treatment and secondary prevention of venous thromboembolism (VTE) in select patients with hypercoagulable disorders. An electronic P...

see more →

News  11 results

March 2019
https://www.mdedge.com/dermatology/article/194337/medical-dermatology/march-2019
Donna Bilu Martin, MD

Feb 12th, 2019 - Livedoid vasculopathy, also known as atrophie blanche and PURPLE (painful purpuric ulcers with reticular pattern of the lower extremities) is a rare, chronic vascular condition. It is a vasculopathy rather than a vasculitis as the former is caused.

A 60-year-old white woman presented with a 3-month history of a painful, nonhealing ulceration on her left lateral lower leg
https://www.mdedge.com/dermatology/article/194337/medical-dermatology/60-year-old-white-woman-presented-3-month-history?channel=39212
Donna Bilu Martin, MD

Feb 12th, 2019 - Livedoid vasculopathy, also known as atrophie blanche and PURPLE (painful purpuric ulcers with reticular pattern of the lower extremities) is a rare, chronic vascular condition. It is a vasculopathy rather than a vasculitis as the former is caused.

Terra Firma-Forme Dermatosis Mimicking Livedo Racemosa
https://www.mdedge.com/dermatology/article/174708/pigmentation-disorders/terra-firma-forme-dermatosis-mimicking-livedo
Christina H. Walker, MD, Ashley Sturgeon, MD et. al.

Sep 13th, 2018 - To the Editor: A 17-year-old adolescent boy presented with dark spots on the legs and back of 2 months’ duration. He was not taking any medications and the spots could not be washed away by scrubbing with soap and water.

Pregnancy-Linked VTE Risk Varies by Type of Thrombophilia
https://www.medpagetoday.com/obgyn/pregnancy/68853

Oct 27th, 2017 - Absolute risk of pregnancy-associated venous thromboembolism (VTE) varied depending on the type of thrombophilia among women with a family history of VTE, a systematic review and meta-analysis found. While all thrombophilias increased the risk of ...

Prevention of stroke in patients with prior stroke or transient ischemic attack
https://www.mdedge.com/familymedicine/article/96582/prevention-stroke-patients-prior-stroke-or-transient-ischemic-attack/page/0/1
Family Practice News;

Jan 23rd, 2015 - Hypercoagulation The utility of screening for factor V Leiden, protein C deficiency, antiphospholipid antibodies, or other thrombophilic states is unclear. Anticoagulation can be considered if a coagulation abnormality is found, and if anticoagula.

see more →